Early Severe Illness TrAnslational BioLogy InformaticS in Humans
Recruiting now
Conditions studied: Sepsis, ARDS, Critical Illness, Neurocognitive Dysfunction, Shock, Septic, Ventilator Associated Pneumonia, Immune Suppression, Inflammation, SIRS
In brief
Advanced stages of the response to life-threatening infection, severe trauma, or other physiological insults often lead to exhaustion of the homeostatic mechanisms that sustain normal blood pressure and oxygenation. These syndromic presentations often meet the diagnostic criteria of sepsis and/or the acute respiratory distress syndrome (ARDS), the two most common syndromes encountered in the intensive care unit (ICU). Although critical illness syndromes, such as sepsis and ARDS, have separate clinical definitions, they often overlap clinically and share several common injury mechanisms. Moreover, there are no specific therapies for critically ill patients, and as a consequence, approximately 1 in 4 patients admitted to the ICU will not survive. The purpose of this observational study is to identify early patient biologic factors that are present at the time of ICU admission that will help diagnose critical illness syndromes earlier, identify who could benefit most from specific therapies, and enable the discovery of new treatments for syndromes such as sepsis and ARDS.
Key facts
- Study ID
- NCT05591924
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- People needed
- 1000
- Starts
- 2024-04-26
- Expected to finish
- 2034-12-31
- Last updated by the study team
- 2025-10-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age ≥18 years old
- ≤48h since ICU admission
- ICU admission within 72h of presentation to the emergency department (ER)
- Clinical critical illness suspected on the basis of any one of the following:
- Altered mental status (GCS<15)
- Cardiovascular collapse (presence of any: Heart rate >90, systolic blood pressure <90, presence of vasopressors, lactate >2.0)
- Respiratory collapse (presence of any: respiratory rate >20, PaCO₂ <32 mm Hg, supplemental oxygen, invasive or non-invasive ventilation)
- Suspected severe infection (presence of any: temperature >38°C or <36°C, white blood cell (WBC) count >12,000/mm³ or <4,000/mm³, presence of 1 or more antibiotics at the time of ICU admission)
You may not qualify if…
- Age <18 years old
- >72h since ICU admission
- Admission to ICU in patients >72h after the presentation to the ER
- No evidence of critical illness (ICU admission due to bed-spacing)
Where it is running
- Aleks Leligdowicz — London, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.